TID-1 L Inhibitors
TID-1 L inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the TID-1 L protein, a member of the TID (TGF-beta-induced) family that plays a role in various cellular processes, including signal transduction and stress response. These inhibitors primarily function by binding to key regions of the TID-1 L protein, such as its active site or other critical functional domains that facilitate interactions with other proteins and signaling pathways. By occupying these essential sites, TID-1 L inhibitors effectively block the protein's ability to participate in normal biological functions, such as modulating cellular responses to stress or signaling cues. Some of these inhibitors may also act through allosteric mechanisms, whereby they bind to regions away from the active site, inducing conformational changes that hinder the protein's activity. The interactions between TID-1 L inhibitors and the protein are stabilized by a variety of non-covalent forces, including hydrogen bonds, hydrophobic interactions, van der Waals forces, and ionic interactions, ensuring that the inhibitors remain stably bound and effectively disrupt the protein's functions.
Structurally, TID-1 L inhibitors exhibit considerable diversity, which allows them to interact specifically with the TID-1 L protein. These inhibitors often incorporate functional groups such as hydroxyl, carboxyl, or amine groups, which facilitate hydrogen bonding and ionic interactions with key residues within the protein's binding pockets. Many TID-1 L inhibitors also feature aromatic rings or heterocyclic structures that enhance hydrophobic interactions with non-polar regions of the protein, contributing to the stability and efficacy of the inhibitor-protein complex. The physicochemical properties of these inhibitors, including molecular weight, solubility, lipophilicity, and polarity, are carefully optimized to ensure effective binding and stability in a variety of biological environments. This balance between hydrophilic and hydrophobic regions allows TID-1 L inhibitors to engage both polar and non-polar areas of the protein, ensuring robust and efficient inhibition of TID-1 L activity across diverse cellular contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, could downregulate TID-1 L expression by promoting acetylation of histone proteins, thus altering the chromatin structure and decreasing gene transcription efficiency for genes like TID-1 L. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine could lead to the hypomethylation of the TID-1 L gene promoter, which would typically decrease its expression by allowing transcription factors more access to the DNA. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could downregulate TID-1 L expression by binding to retinoic acid receptors that interact with promoter regions of target genes, thereby altering the transcriptional activity of genes including TID-1 L. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which could lead to a decrease in TID-1 L expression by reducing the rate of protein translation, and thus, decreasing the overall protein synthesis within cells, including TID-1 L. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
As a proteasome inhibitor, MG-132 could lead to an accumulation of misfolded proteins, which may trigger a cellular stress response, and subsequently reduce TID-1 L expression as part of a broader decrease in protein synthesis to mitigate stress. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could decrease TID-1 L expression by activating sirtuins that deacetylate histones, leading to a more compact chromatin structure and reduced access for the transcription machinery to the TID-1 L gene. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine raises endosomal pH, which could disrupt cellular signaling pathways linked to transcriptional regulation, leading to a potential decrease in TID-1 L transcription as a secondary effect. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002, a PI3K inhibitor, could decrease TID-1 L expression by obstructing the PI3K/Akt pathway, which is often involved in promoting transcription and cell survival, thus leading to a reduction in the transcription of survival-related genes like TID-1 L. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may decrease TID-1 L expression by inhibiting NF-κB signaling, which is responsible for the transcription of many genes involved in cell survival and stress responses, potentially including TID-1 L. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, by inhibiting histone deacetylases, could lead to enhanced histone acetylation around the TID-1 L gene, paradoxically leading to reduced transcription if it disrupts the binding of transcriptional activators or co-activators. | ||||||